Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Zacks Research cut their Q2 2025 EPS estimates for shares of Sanofi in a research report issued on Wednesday, February 19th.

Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form ...

Ariel International Fund declined -5.11% in the quarter, outperforming both its primary and secondary benchmark, the MSCI ...

Ariel International Composite declined -4.98% gross of fees (-5.12% net of fees) in the quarter, ahead of MSCI EAFE and MSCI ...